07:00 , Aug 23, 2010 |  BioCentury  |  Strategy

The future emerges

Emergent BioSolutions Inc. has sustained itself for years with a steady stream of government grants and contracts for infectious disease and biodefense products, but has been looking for acquisitions that could diversify its revenue stream...
08:00 , Mar 5, 2007 |  BC Week In Review  |  Company News

Emergent BioSolutions, U.S. Department of Health and Human Services infectious news

EBS delivered about 1 million doses of its BioThrax anthrax vaccine to HHS, for which the company will receive about $22 million in revenue this quarter. The delivery is the last under a 5 million...
08:00 , Dec 18, 2006 |  BC Week In Review  |  Company News

Emergent BioSolutions, U.S. Department of Health and Human Services infectious news

EBS delivered about 3 million doses of its BioThrax anthrax vaccine to HHS under a contract awarded to EBS's BioPort Corp. earlier this year (see BioCentury, May 8). EBS will receive about $75 million in...
01:15 , Oct 18, 2006 |  BC Extra  |  Politics & Policy

DoD resumes mandatory Anthrax vaccinations

The Department of Defense said that within the next 30-60 days it will resume a mandatory Anthrax vaccination program for military personnel. The department said mandatory vaccinations are limited to units designated for homeland bioterrorism...
07:00 , Jun 12, 2006 |  BioCentury  |  Finance

Ebb & Flow

Nobody disputes the notion that Elan's fortunes are more closely tied to multiple sclerosis drug Tysabri natalizumab than partner Biogen Idec's . Indeed, Tysabri news - be it good or bad - has typically led...
07:00 , May 8, 2006 |  BC Week In Review  |  Company News

BioPort infectious news

The Department of Health and Human Services awarded BioPort a second contract to supply 5 million doses of BioThrax anthrax vaccine adsorbed (AVA) under the Project BioShield program. The contract is worth $120 million. HHS...
23:34 , May 5, 2006 |  BC Extra  |  Company News

BioPort gets $120M vaccine contract

HHS awarded BioPort (Lansing, Mich.) a second contract to supply 5 million doses of the company's BioThrax anthrax vaccine adsorbed (AVA) under the Project BioShield program. The contract is worth $120 million. HHS purchased the...
07:00 , Apr 10, 2006 |  BC Week In Review  |  Company News

VaxGen infectious news

Rep. Mike Rogers (R-Mich.) said he has asked for a congressional investigation of HHS's handling of Project BioShield. In particular, Rogers wants the Oversight and Investigations subcommittee of the House Committee on Energy and Commerce...
07:00 , Apr 10, 2006 |  BioCentury  |  Finance

Ebb & Flow

Lion bioscience (FSE:LIO) was Europe's biggest-ever biotech IPO - the company raised E227.9 million ($205.5 million) in August 2000 on the promise of its bioinformatics business. Within a few weeks, the stock more than doubled...
00:09 , Apr 7, 2006 |  BC Extra  |  Company News

Congressman wants probe of VaxGen contract

Rep. Mike Rogers (R-Mich.) said he has asked for a congressional investigation of HHS's handling of Project BioShield. In particular, Rogers wants the Oversight and Investigations subcommittee of the House Committee on Energy and Commerce...